Impact of Genetic Polymorphisms of Vegf Pathway on the Response to Bevacizumab in Metastatic Colorectal Cancer (mcrc): Ancillary Study of Prodige 9 Trial.
Journal of clinical oncology（2016）
摘要
3534Background: Bevacizumab (Bev) is widely used in mCRC but there is no validated predictive factor. Several studies have reported the impact of SNPs in the Vascular Endothelial Growth Factor-A (V...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要